本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Neurosense Therapeutics Ltd

0.8800
-0.0240-2.65%
盤後0.88000.00000.00%17:52 EST
成交量:6.94萬
成交額:6.16萬
市值:2,913.93萬
市盈率:-2.33
高:0.9098
開:0.9090
低:0.8700
收:0.9040
52周最高:2.60
52周最低:0.6801
股本:3,311.28萬
流通股本:2,210.79萬
量比:0.23
換手率:0.31%
股息:- -
股息率:- -
每股收益(TTM):-0.3778
每股收益(LYR):-0.5489
淨資產收益率:-2478.16%
總資產收益率:-303.90%
市淨率:-56.15
市盈率(LYR):-1.60

資料載入中...

2025/08/15

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/04/07

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/01/16

SEC問詢函

Form CORRESP - Correspondence
2025/01/06

SEC問詢函

Form CORRESP - Correspondence
2024/12/13

SEC問詢函

Form CORRESP - Correspondence
2024/12/09

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/22

SEC問詢函

Form CORRESP - Correspondence
2024/11/19

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/05/21

SEC問詢函

Form CORRESP - Correspondence
2024/05/20

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/10

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/04/04

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/04

SEC問詢函

Form CORRESP - Correspondence
2023/09/01

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/08/31

SEC問詢函

Form CORRESP - Correspondence
2023/08/15

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/08/14

SEC問詢函

Form CORRESP - Correspondence
2023/07/21

招股説明書

Form F-1 - Registration statement for certain foreign private issuers